Australia markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.2200+0.2000 (+4.98%)
At close: 04:00PM EDT
4.0100 -0.21 (-4.98%)
After hours: 04:29PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts7488
Avg. Estimate-0.38-0.41-1.41-1.65
Low estimate-0.44-0.45-1.55-1.89
High estimate-0.3-0.36-1.32-1.16
Year ago EPS-0.29-0.31-1.22-1.41
Revenue estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts7365
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202129/06/202129/09/202130/12/2021
Est. EPS-0.33-0.31-0.28-0.33
Actual EPS-0.29-0.31-0.35-0.36
Difference0.040-0.07-0.03
Surprise %12.10%0.00%-25.00%-9.10%
EPS trendCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Current estimate-0.38-0.41-1.41-1.65
7 days ago-0.38-0.41-1.41-1.65
30 days ago-0.37-0.41-1.41-1.65
60 days ago-0.36-0.39-1.39-1.61
90 days ago-0.36-0.39-1.39-1.61
EPS revisionsCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIMVTIndustrySector(s)S&P 500
Current qtr.-31.00%N/AN/AN/A
Next qtr.-32.30%N/AN/AN/A
Current year-15.60%N/AN/AN/A
Next year-17.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A